Equity Components [Axis]
Common Stock [Member]
Additional Paid-in-Capital [Member]
Accumulated Deficit
Antidilutive Securities [Axis]
Outstanding Options [Member]
Outstanding Warrants [Member]
Convertible Preferred Stock [Member]
Class of Stock [Axis]
Series A Convertible Preferred Stock [Member]
Related Party [Axis]
Investor [Member]
Warrants [Member]
Plan Name [Axis]
2015 Long-term Incentive Plan [Member]
Award Type [Axis]
Stock Options [Member]
Award Date [Axis]
2020 [Member]
2021 [Member]
Type of Arrangement and Non-arrangement Transactions [Axis]
Exclusive License Agreement [Member]
Title of Individual [Axis]
Dr. Brent Satterfield [Member]
Dr. Satterfield [Member]
Convertible Preferred Stock [Member]
Legal Entity [Axis]
Two Companies [Member]
Four Individuals [Member]
Ten Employees and Two Member of Board of Directors [Member]
Three Companies [Member]
Professional Services Agreement [Member]
2022 [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Common Stock [Member]
Revision of Prior Period [Axis]
As Previously Reported [Member]
Adjustments [Member]
Restatement [Axis]
As previously Reported [Member]
Adjustment [Member]
Cover [Abstract]
Entity Registrant Name
Entity Central Index Key
Document Type
Document Period End Date
Amendment Flag
Amendment Description
Current Fiscal Year End Date
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Shell Company
Entity Common Stock, Shares Outstanding
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement of Financial Position [Abstract]
ASSETS:
Current assets
Cash and cash equivalents
Accounts receivable, net
Inventory
Prepaid expenses
Total current assets
Property and equipment, net
Investment in joint venture
Total assets
Liabilities and stockholders' equity
Current liabilities
Accounts payable
Accrued expenses
Accrued expenses (related party)
Deferred revenue
Total current liabilities
Accrued expenses-long-term (related party)
Total liabilities
Commitments and contingencies (Note 1)
Stockholders' equity
Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 and 25,600 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively
Common Stock, $0.001 par value; 100,000,000 shares authorized; 27,991,042 and 17,342,922 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity
Convertible preferred stock, par value
Convertible preferred stock , shares authorized
Convertible preferred stock, shares issued
Convertible preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Net revenue
Cost of revenue
Gross profit
Operating expenses
Sales and marketing
Administrative and general
Research and development
Depreciation and amortization
Total operating expenses
Income (loss) from operations
Other income (expense)
Interest income
Interest expense
Gain on disposition of assets
Gain (loss) on equity method investment in joint venture
Total other income (expense)
Income (loss) before income taxes
Provision for income taxes
Net income (loss)
Net income (loss) per common share:
Basic
Diluted
Weighted average shares outstanding:
Basic
Diluted
Statement of Cash Flows [Abstract]
Cash flows from operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Stock-based compensation expense
Accretion of notes payable discount
Gain on disposition of assets
Loss (gain) from equity method investment
Changes in assets and liabilities:
Accounts and other receivable
Prepaid and other assets
Inventory
Deffered revenue
Accounts payable and accrued expenses
Net cash used in operating activities
Cash flows from investing activities
Purchase of property and equipment
Investment in joint venture
Net cash used in investing activities
Cash flows from financing activities
Proceeds from sale of common stock
Proceeds from sale of preferred stock
Proceeds from exercise of options and warrants
Payment of offering costs
Net cash provided by financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Interest paid
Income taxes paid
Supplemental disclosure of non-cash investing and financing transactions
Inventory moved to property, plant and equipment
Statement [Table]
Statement [Line Items]
Beginning balance
Beginning balance, shares
Public offering, net of offering costs
Public offering, net of offering costs, shares
Issuance of common stock for warrant exercises
Issuance of common stock for warrant exercises, shares
Issuance of common stock for option and warrant exercises
Issuance of common stock for option and warrant exercises, shares
Stock-based compensation expense
Stock-based compensation expense, shares
Issuance of common stock for services
Issuance of common stock for services, shares
Conversion of preferred stock to common
Conversion of preferred stock to common, shares
Issuance of preferred stock
Issuance of preferred stock, shares
Net Income (loss)
Ending balance
Ending balance, shares
Statement of Stockholders' Equity [Abstract]
Public offering costs
Accounting Policies [Abstract]
Overview and Basis of Presentation
Summary of Significant Accounting Policies
Accounting Changes and Error Corrections [Abstract]
Restatement of Condensed Consolidated Financial Statements (Unaudited)
Equity [Abstract]
Equity
Share-based Payment Arrangement, Disclosure [Abstract]
Stock-Based Compensation
Related Party Transactions [Abstract]
Related Party Transactions
Leases [Abstract]
Lease Obligations
Subsequent Events [Abstract]
Subsequent Events
Accounts Receivable
Equity-Method Investments
Inventory
Revenue Recognition
Earnings (Loss) Per Share
Research and Development
Recent Accounting Pronouncements
Commitments and Contingency
Schedule of Restatement of Unaudited Consolidated Financial Statements
Schedule of Fair Value of Options Weighted Average Assumptions
Schedule of Option Activity
Schedule of Warrant Activity
Schedule of Unrecognized Stock-based Compensation
Schedule of Ongoing Lease Obligation
Accounts receivable
Doubtful accounts
Inventory finished goods
Inventory raw materials
Potentially dilutive shares
Research and development cost
Net income per common share for basic and diluted
Stockholders' equity
Total current assets
Total assets
Total current liabilities
Total liabilities
Total stockholders' equity
Total liabilities and stockholders' equity
Gross profit
Total operating expenses
Income from operations
Total other expense (expense)
Income (loss) before income taxes
Net income
Basic income (loss) per common share
Diluted income (loss) per common share
Weighted average common shares outstanding basic
Weighted average common shares outstanding diluted
Net cash used in operating activities
Net cash used in investing activities
Net cash provided by financing activities
Net increase in cash and cash equivalents
Schedule of Stock by Class [Table]
Class of Stock [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Number of common stock issued
Sale of common stock purchase price per shares
Issuance of common stock gross proceeds
Net proceeds from issuance of common stock
Offering costs
Number of common stock issued, value
Stock issued during period, warrant exercised value
Warrants exercisable price per share
Number of conversion of shares issued
Conversion of preferred stock
Conversion of preferred stock, price per shares
Number of warrants exercised
Number of shares issued for services
Value of shares issued for services
Proceeds from warrants exercise
Proceeds from stock option exercised
Number of stock option exercised
Purchase price
Promissory note
Equity ownership percentage
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate number of common shares reserved
Unissued common stock options authorized shares
Stock based compensation
Intrinsic value of options outstanding
Unvested option shares outstanding
Intrinsic value of options and warrants exercised
Unrecognized stock-based compensation
Share-based Payment Arrangement [Abstract]
Risk free interest rate
Expected life (years)
Expected volatility
Expected dividend yield
Stock price
Options Outstanding, Beginning
Options Outstanding, Granted
Options Outstanding, Expired
Options Outstanding, Forfeited/Cancelled
Options Outstanding, Exercised
Options Outstanding, Ending
Weighted Average Exercise Price Outstanding, Beginning
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Expired
Weighted Average Exercise Price Forfeited/Cancelled
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Outstanding, Ending
Weighted Average Fair Value Outstanding, Beginning
Weighted Average Fair Value Granted
Weighted Average Fair Value Expired
Weighted Average Fair Value Forfeited/Cancelled
Weighted Average Fair Value Exercised
Weighted Average Fair Value Outstanding, Ending
Weighted-average Remaining Contractual Life (years) Outstanding, Beginning
Weighted-average Remaining Contractual Life (years) Granted
Weighted-average Remaining Contractual Life (years) Forfeited/Cancelled
Weighted-average Remaining Contractual Life (years) Exercised
Weighted-average Remaining Contractual Life (years) Outstanding, Ending
Number of Warrants Outstanding, Beginning
Number of Warrants Outstanding, Granted
Number of Warrants Outstanding, Expired
Number of Warrants Outstanding, Forfeited/Cancelled
Number of Warrants Outstanding, Exercised
Number of Warrants Outstanding, Ending
Weighted Average Exercise Price, Beginning
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Expired
Weighted Average Exercise Price, Forfeited/Cancelled
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Ending
Weighted Average Fair Value, Beginning
Weighted Average Fair Value, Granted
Weighted Average Fair Value, Expired
Weighted Average Fair Value, Forfeited/Cancelled
Weighted Average Fair Value, Exercised
Weighted Average Fair Value, Ending
Weighted-average Remaining Contractual Life (Years), Beginning
Weighted-average Remaining Contractual Life (Years), Granted
Weighted-average Remaining Contractual Life (Years), Exercised
Weighted-average Remaining Contractual Life (Years), Ending
Total
Accrued royalties
Increase in Royalties Payable, per month
Due to related party
Lease term
Area of land
Payments for rent
Lease expiration date
Rent expenses
2020 (remainder)
2021
2022
2023
2024
Total lease payments
Stock issued for exercise of warrants.
Stock issued for exercise of warrants, shares.
Stock issued during pPeriod value preferred stock.
Stock issued during period shares preferred stock.
Joint Venture Agreement [Member]
Series A Convertible Preferred Stock [Member]
Two Indivuduals [Member]
Professional Services Agreements [Member]
Three Companies [Member]
Two Companies [Member]
2015 Long-term Incentive Plan [Member]
Stock Options [Member]
Adjusted to Issuance of Equity [Member]
Sales and Marketing [Member]
Repurchasing Of Market Licensing Agreement [Member]
Four Companies [Member]
One Company [Member]
2020 [Member]
2021 [Member]
Dr. Satterfield [Member]
Exclusive License Agreement [Member]
Dr. Brent Satterfield [Member]
Convertible Preferred Stock [Member]
Proceeds from exercise of options and warrants.
Inventory moved to property, plant and equipment.
Issuance of Common Stock for option and warrant exercises.
Issuance of Common Stock for option and warrant exercises, shares
Outstanding Options [Member]
Outstanding Warrants [Member]
Four Individuals [Member]
Ten Employees and Two Member of Board of Directors [Member]
Professional Services Agreement [Member]
2022 [Member]
Common Stock [Member]
Public offering costs.
Share-based Compensation Arrangement by Share-based Payment Award, Options and Warrants, Exercises in Period, Intrinsic Value.
Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value.
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted-average Remaining Contractual Life (years) Options granted.
Weighted-average Remaining Contractual Life (years) Options Forfeited options.
Weighted-average Remaining Contractual Life (years) Options Exercised.
Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan.
Share-based compensation arrangements by share-based payment award, non-options, grants in period, weighted average exercise price.
Weighted average price at which grantees could have acquired the underlying shares with respect to non-options of the plan that expired.
Weighted average price at which grantees could have acquired the underlying shares with respect to non-options that were terminated.
Share-based compensation arrangements by share-based payment award, non-options, exercise in period, weighted average exercise price
Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan.
Share-based compensation arrangement by share-based payment award, non-option, weighted average exercise price
Share-based compensation arrangement by share-based payment award, non-option, granted in period, weighted average exercise price.
Share-based compensation arrangement by share-based payment award, non-option, expirations, weighted average exercise price.
Share-based compensation arrangement by share-based payment award, non-option, forfeitures, weighted average exercise price.
Share-based compensation arrangement by share-based payment award, non-option, exercise in period, weighted average exercise price.
Share-based compensation arrangement by share-based payment award, non-options, outstanding, weighted average remaining contractual term.
Share-based compensation arrangement by share-based payment award, non-options, granted in period, weighted average remaining contractual term.
Share-based compensation arrangement by share-based payment award, non-options, exercise in period, weighted average remaining contractual term.
Share-based compensation arrangement by share-based payment award, non-options, outstanding, weighted average remaining contractual term.
Net proceeds from issuance of common stock.
Stock issued during period, value warrant options exercised.
Conversion of preferred stock, price per shares.
Purchase price.
ConvertiblePreferredStocksMember
CommonStockOneMember
Interest Expense, Other
Gain (Loss) on Sale of Equity Investments
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Inventories
Increase (Decrease) in Deferred Income Taxes
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Interest in Joint Venture
Payments of Stock Issuance Costs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Shares, Outstanding
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
Inventory, Policy [Policy Text Block]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonOutstandingWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValue
Lessee, Operating Lease, Liability, to be Paid